CARLOS BOTERO: Open Payments
NPI 1902880933 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 19 payments from 12 companies in 2025. Trend: 2023 $2,928 · 2024 $1,994 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Medtronic, Inc. | 2 | $43 |
| Abbott Laboratories | 2 | $38 |
| PROTEGA PHARMACEUTIALS INC | 2 | $34 |
| SI-BONE, INC. | 2 | $33 |
| TerSera Therapeutics LLC | 1 | $26 |
| Tonix Medicines, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $19 |
Products named: QUTENZA, JOURNAVX, PROCLAIM, ROXYBOND, Prialt, XTAMPZA, SYNCHROMEDII, INTELLIS ADAPTIVESTIM.
Industry payments across FL — which companies pay providers there.
